Table 1.
Patients characteristics.
| PBC patients (n = 390) | UDCA-naïve treatment (n = 259) | UDCA treatment (n = 131) | |
|---|---|---|---|
| Gender (female/male) | 351/39 | 229/30 | 122/9 |
| Age (median, quartile) | 58.0 (16.0) | 58.0 (16.0) | 57.0 (14.0) |
| AMA-M2 +/− (%) | 370/20 (94.9) | 251/8 (96.9) | 119/12 (90.8) |
| Anti-gp210 +/− (%) | 129/261 (33.1) | 88/171 (34.2) | 41/90 (31.3) |
| Anti-sp100 +/− (%) | 80/310 (20.5) | 64/195 (24.7) | 16/115 (12.2) |
| ALBI scorea | |||
| 1/2/3 (%) | 136/173/73 (35.6/45.3/19.1) | 88/120/46 (34.6/47.2/18.1) | 48/53/27 (37.5/41.4/21.1) |
| Cirrhosisb | |||
| +/− (%) | 197/163 (54.7/45.3) | 114/131 (46.5/53.5) | 83/32 (72.2/27.8) |
Abbreviations are same as in the text.
a
available in 382 patients.
b
available in 360 patients.